| 1. |
Wegener-Panzer A, Cleaveland R, Wendel EM, et al. Clinical and imaging features of children with autoimmune encephalitis and MOG antibodies. Neurol Neuroimmunol Neuroinflamm, 2020, 7(4): e731.
|
| 2. |
Caparo-Zamalloa C, Alvarez-Toledo K, Yamunaque-Chunga C, et al. Autoimmune neurology: co-occurrence of anti-NMDAR encephalitis and anti-MOG associated disease, report of a case. J Neuroimmunol, 2021, 358: 577663.
|
| 3. |
Banks SA, Morris PP, Chen JJ, et al. Brainstem and cerebellar involvement in MOG-IgG-associated disorder versus aquaporin-4-IgG and MS. J Neurol Neurosurg Psychiatry, 2020, 6(1): 14-18.
|
| 4. |
Hegen H, Reindl M. Recent developments in MOG-IgG associated neurological disorders. Ther Adv Neurol Disord, 2020, 13: 1279166703.
|
| 5. |
Peschl P, Bradl M, Hoftberger R, et al. Myelin oligodendrocyte glycoprotein: deciphering a target in inflammatory demyelinating diseases. Front Immunol, 2017, 8: 529.
|
| 6. |
Reindl M, Waters P. Myelin oligodendrocyte glycoprotein antibodies in neurological disease. Nat Rev Neurol, 2019, 15(2): 89-102.
|
| 7. |
Jarius S, Paul F, Aktas O, et al. MOG encephalomyelitis: international recommendations on diagnosis and antibody testing. Nervenarzt, 2018, 89(12): 1388-1399.
|
| 8. |
Ferilli M, Valeriani M, Papi C, et al. Clinical and neuroimaging characteristics of MOG autoimmunity in children with acquired demyelinating syndromes. Mult Scler Relat Disord, 2021, 50: 102837.
|
| 9. |
Tian F, Liu X, Yang C, et al. MOG antibody-positive cerebral cortical encephalitis: two case reports and literature review. Int J Dev Neurosci, 2021, 81(4): 342-351.
|
| 10. |
崔東清, 左瑤, 劉燕霞, 等. 髓鞘少突膠質細胞糖蛋白抗體相關疾病的臨床及影像學特點. 中華神經科雜志, 2020, 53(1): 19-24.
|
| 11. |
劉 舉, 潘佳麗, 楊曉艷, 等. 成人MOG抗體陽性腦炎患者臨床及影像學特征分析. 中國臨床神經科學, 2022, 30(2): 209-215.
|
| 12. |
Denève M, Biotti D, Patsoura S, et al. MRI features of demyelinating disease associated with anti-MOG antibodies in adults. Journal of Neuroradiology, 2019, 46(5): 312-318.
|
| 13. |
Lopez-Chiriboga AS, Majed M, Fryer J, et al. Association of MOG-IgG serostatus with relapse after acute disseminated encephalomyelitis and proposed diagnostic criteria for MOG-IgG-associated disorders. JAMA Neurol, 2018, 75(11): 1355-1363.
|
| 14. |
Jarius S, Paul F, AKtas O, et al. MOG encephalomyelitis: international recommendations on diagnosis and antibody testing. Journal of Neuroinflammation, 2018, 15(1): 134-140.
|
| 15. |
中國免疫學會神經免疫分會. 抗髓鞘少突膠質細胞糖蛋白免疫球蛋白 G 抗體相關疾病診斷和治療中國專家共識. 中國神經免疫學和神經病學雜志, 2020, 27(2): .91-92.
|
| 16. |
Salama S, Khan M, Pardo S, et al. MOG antibody-associated encephalomyelitis/encephalitis. Mult Scler, 2019, 25(11): 1427-1433.
|
| 17. |
Hamid S, Whittam D, Saviour M, et al. Seizures and encephalitis in Myelin oligodendrocyte glycoprotein IgG disease vs Aquaporin 4 IgG disease. Jama Neurol, 2018, 75(1): 65-71.
|
| 18. |
Ogawa R, Nakashima I, Takahashi T, et al. MOG antibody-positive, benign, unilateral, cerebral cortical encephalitis with epilepsy. Neurol Neuroimmunol Neuroinflamm, 2017, 4(2): e322.
|
| 19. |
Fujimori J, Takai Y, Nakashima I, et al. Bilateral frontal cortex encephalitis and paraparesis in a patient with anti-MOG antibodies. J Neurol Neurosurg Psychiatry, 2017, 88(6): 534-536.
|
| 20. |
Wang L, Zhangbao J, Zhou L, et al. Encephalitis is an important clinical component of myelin oligodendrocyte glycoprotein antibody associated demyelination: a single-center cohort study in Shanghai, China. Eur J Neurol, 2019, 26(1): 168-174.
|
